The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...

For ultrasound-guided prostate biopsy, a transperineal approach is emerging as a superior alternative to the transrectal approach because the former is associated with a lower risk of infection. This ...

Tommy Cannon shares prostate cancer update with fans and urges men to get tested - The comedian also recalled a particularly ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

First results of the PRIMARY2 randomized phase III trial support consideration of PSMA PET/CT in diagnostic work-up ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...